Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China

PURPOSE: Molecular targeted agents (MTAs) plus immune checkpoint inhibitors (ICIs) treatment for advanced hepatocellular carcinoma (HCC) has shown an exciting prospect. This study aimed to report the efficacy of the Simultaneous and Sequential use of them in a real-world practice. PATIENTS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Huang, Liang, Ge, Chao, Zhu, Xingwu, Qiu, Maixuan, Chen, Chaopan, Wei, Shaohua, Yan, Yiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290454/
https://www.ncbi.nlm.nih.gov/pubmed/37361905
http://dx.doi.org/10.2147/JHC.S415941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290454/
https://www.ncbi.nlm.nih.gov/pubmed/37361905
http://dx.doi.org/10.2147/JHC.S415941

Ejemplares similares